Cancer is the second leading cause of death worldwide and patients are in urgent need of
therapies that can effectively target cancer with minimal off-target side effects. Exosomes are …

Exosomes are nanosized membranous vesicles secreted by a variety of cells. Due to their
unique and pharmacologically important properties, cell-derived exosome nanoparticles …

Adriamycin and docetaxel are two agents commonly used in treatment of breast cancer, but
their efficacy is often limited by the emergence of chemoresistance. Recent studies indicate …

Cancer treatment still represents a formidable challenge, despite substantial advancements
in available therapies being made over the past decade. One major issue is poor …

Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …

Exosome-based drug delivery is emerging as a promising field with the potential to
revolutionize therapeutic interventions. Exosomes, which are small extracellular vesicles …

Exosomes are the best options for gene targeting, because of their natural, nontoxic, non-
immunogenic, biodegradable, and targetable properties. By engineering exosome …

Co-delivery of microRNAs and chemotherapeutic drugs into tumor cells is an attractive
strategy for synergetic breast cancer therapy due to their complementary mechanisms. In …

Non-small cell lung cancer (NSCLC) is one of the leading causes of death from cancer
worldwide. The delivery and controlled regulation of miRNAs via exosomes is known as a …

Exosomes are gaining increasing attention as drug delivery vehicles due to their low toxicity
and ability to functionally transfer biological cargos between cells. However, the therapeutic …